- Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
- Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
- Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.
Gainers
- Indaptus Therapeutics INDP shares increased by 68.88% to $11.94 during Wednesday's pre-market session. The market value of their outstanding shares is at $64.5 million.
- Sonnet BioTherapeutics SONN shares rose 22.18% to $0.69. The company's market cap stands at $40.1 million.
- Innate Pharma IPHA shares moved upwards by 13.71% to $6.22. The company's market cap stands at $492.2 million. As per the press release, H1 earnings came out today.
- HOOKIPA Pharma HOOK shares rose 12.05% to $6.97. The company's market cap stands at $208.3 million.
- Cellect Biotechnology APOP stock increased by 9.71% to $6.44. The company's market cap stands at $25.2 million.
- 180 Life Sciences ATNF shares moved upwards by 7.58% to $6.1. The company's market cap stands at $205.9 million.
Losers
- Nuwellis NUWE stock fell 28.19% to $2.65 during Wednesday's pre-market session. The market value of their outstanding shares is at $17.3 million.
- ChromaDex CDXC shares declined by 19.83% to $5.58. The market value of their outstanding shares is at $380.5 million.
- Theravance Biopharma TBPH stock decreased by 19.78% to $6.45. The company's market cap stands at $473.8 million.
- Avalo Therapeutics AVTX stock fell 16.8% to $2.13. The market value of their outstanding shares is at $204.4 million.
- Calliditas Therapeutics CALT stock declined by 7.11% to $22.74. The company's market cap stands at $595.1 million.
- aTyr Pharma LIFE shares fell 4.45% to $8.6. The company's market cap stands at $145.5 million.
ATNF180 Life Sciences Corp
$1.04-%
Edge Rankings
Momentum
10.05
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in